167 related articles for article (PubMed ID: 16785312)
21. NY-ESO-1 encodes DRB1*0401-restricted epitopes recognized by melanoma-reactive CD4+ T cells.
Zarour HM; Storkus WJ; Brusic V; Williams E; Kirkwood JM
Cancer Res; 2000 Sep; 60(17):4946-52. PubMed ID: 10987311
[TBL] [Abstract][Full Text] [Related]
22. Immunogenicity of dendritic cells pulsed with MAGE3, Survivin and B-cell maturation antigen mRNA for vaccination of multiple myeloma patients.
Hobo W; Strobbe L; Maas F; Fredrix H; Greupink-Draaisma A; Esendam B; de Witte T; Preijers F; Levenga H; van Rees B; Raymakers R; Schaap N; Dolstra H
Cancer Immunol Immunother; 2013 Aug; 62(8):1381-92. PubMed ID: 23728352
[TBL] [Abstract][Full Text] [Related]
23. Efficient ex vivo induction of T cells with potent anti-tumor activity by protein antigen encapsulated in nanoparticles.
Rosalia RA; Silva AL; Camps M; Allam A; Jiskoot W; van der Burg SH; Ossendorp F; Oostendorp J
Cancer Immunol Immunother; 2013 Jul; 62(7):1161-73. PubMed ID: 23613147
[TBL] [Abstract][Full Text] [Related]
24. BDCA-2 signaling inhibits TLR-9-agonist-induced plasmacytoid dendritic cell activation and antigen presentation.
Jähn PS; Zänker KS; Schmitz J; Dzionek A
Cell Immunol; 2010; 265(1):15-22. PubMed ID: 20673884
[TBL] [Abstract][Full Text] [Related]
25. Antigen delivery to plasmacytoid dendritic cells via BST2 induces protective T cell-mediated immunity.
Loschko J; Schlitzer A; Dudziak D; Drexler I; Sandholzer N; Bourquin C; Reindl W; Krug AB
J Immunol; 2011 Jun; 186(12):6718-25. PubMed ID: 21555533
[TBL] [Abstract][Full Text] [Related]
26. Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes.
Thornton BP; Vĕtvicka V; Ross GD
J Immunol; 1994 Feb; 152(4):1727-37. PubMed ID: 8120381
[TBL] [Abstract][Full Text] [Related]
27. Keyhole limpet hemocyanin induces the activation and maturation of human dendritic cells through the involvement of mannose receptor.
Presicce P; Taddeo A; Conti A; Villa ML; Della Bella S
Mol Immunol; 2008 Feb; 45(4):1136-45. PubMed ID: 17765973
[TBL] [Abstract][Full Text] [Related]
28. Presentation of tumor antigens by phagocytic dendritic cell clusters generated from human CD34+ hematopoietic progenitor cells: induction of autologous cytotoxic T lymphocytes against leukemic cells in acute myelogenous leukemia patients.
Fujii S; Fujimoto K; Shimizu K; Ezaki T; Kawano F; Takatsuki K; Kawakita M; Matsuno K
Cancer Res; 1999 May; 59(9):2150-8. PubMed ID: 10232602
[TBL] [Abstract][Full Text] [Related]
29. Antigen targeting to plasmacytoid dendritic cells via Siglec-H inhibits Th cell-dependent autoimmunity.
Loschko J; Heink S; Hackl D; Dudziak D; Reindl W; Korn T; Krug AB
J Immunol; 2011 Dec; 187(12):6346-56. PubMed ID: 22079988
[TBL] [Abstract][Full Text] [Related]
30. Monocyte derived dendritic cells from HIV-1 infected individuals partially reconstitute CD4 T-cell responses.
Newton PJ; Weller IV; Williams IG; Miller RF; Copas A; Tedder RS; Katz DR; Chain BM
AIDS; 2006 Jan; 20(2):171-80. PubMed ID: 16511409
[TBL] [Abstract][Full Text] [Related]
31. Membrane transfer from tumor cells overcomes deficient phagocytic ability of plasmacytoid dendritic cells for the acquisition and presentation of tumor antigens.
Bonaccorsi I; Morandi B; Antsiferova O; Costa G; Oliveri D; Conte R; Pezzino G; Vermiglio G; Anastasi GP; Navarra G; Münz C; Di Carlo E; Mingari MC; Ferlazzo G
J Immunol; 2014 Jan; 192(2):824-32. PubMed ID: 24337377
[TBL] [Abstract][Full Text] [Related]
32. Neonatal human autologous dendritic cells pulsed with recombinant protein antigen prime the generation of non-polarized CD4 T-cell effectors.
Matthews NC; Power UF; Reen DJ
Int Immunol; 2007 Jun; 19(6):703-12. PubMed ID: 17493958
[TBL] [Abstract][Full Text] [Related]
33. Optimizing the exogenous antigen loading of monocyte-derived dendritic cells.
Dieckmann D; Schultz ES; Ring B; Chames P; Held G; Hoogenboom HR; Schuler G
Int Immunol; 2005 May; 17(5):621-35. PubMed ID: 15824067
[TBL] [Abstract][Full Text] [Related]
34. Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients.
Lesterhuis WJ; de Vries IJ; Schreibelt G; Lambeck AJ; Aarntzen EH; Jacobs JF; Scharenborg NM; van de Rakt MW; de Boer AJ; Croockewit S; van Rossum MM; Mus R; Oyen WJ; Boerman OC; Lucas S; Adema GJ; Punt CJ; Figdor CG
Clin Cancer Res; 2011 Sep; 17(17):5725-35. PubMed ID: 21771874
[TBL] [Abstract][Full Text] [Related]
35. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C
Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082
[TBL] [Abstract][Full Text] [Related]
36. In vivo targeting of antigens to human dendritic cells through DC-SIGN elicits stimulatory immune responses and inhibits tumor growth in grafted mouse models.
Kretz-Rommel A; Qin F; Dakappagari N; Torensma R; Faas S; Wu D; Bowdish KS
J Immunother; 2007 Oct; 30(7):715-26. PubMed ID: 17893564
[TBL] [Abstract][Full Text] [Related]
37. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
38. Tumor cell loaded type-1 polarized dendritic cells induce Th1-mediated tumor immunity.
Hokey DA; Larregina AT; Erdos G; Watkins SC; Falo LD
Cancer Res; 2005 Nov; 65(21):10059-67. PubMed ID: 16267032
[TBL] [Abstract][Full Text] [Related]
39. Uptake routes of tumor-antigen MAGE-A3 by dendritic cells determine priming of naïve T-cell subtypes.
Moeller I; Spagnoli GC; Finke J; Veelken H; Houet L
Cancer Immunol Immunother; 2012 Nov; 61(11):2079-90. PubMed ID: 22562379
[TBL] [Abstract][Full Text] [Related]
40. Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanoma.
Hersey P; Menzies SW; Halliday GM; Nguyen T; Farrelly ML; DeSilva C; Lett M
Cancer Immunol Immunother; 2004 Feb; 53(2):125-34. PubMed ID: 14600790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
